SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
momo-T/FIF
An SI Board Since October 2003
Posts SubjectMarks Bans
12215 138 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
11115No, but most of the damage had been done before he piped up, anyway. I just wentuck-5/8/2017
11114IIRC wasn't that a technical call? I usually ignore those. If not, then atticus4paws-5/8/2017
11113You saw that Alfredo F. warned twitter types to take care?scaram(o)uche-5/8/2017
11112RXDX Right, once priced, I tried for $6.35, but it didn't come close. Thoutuck-5/8/2017
11111and BTW, Tuck.... kept a small portion of the shares (rxdx). About 10%. (duscaram(o)uche-5/8/2017
11110>> tried for a position, but was afraid to get in in front of pricing of sscaram(o)uche-5/8/2017
11109>> but was afraid to get in in front of pricing of secondary << Uglscaram(o)uche-5/8/2017
11108Somewhere around here, you asked if I still had my bone pile shares in some comptuck-5/8/2017
11107Somewhere around here, you asked if I still had my bone pile shares in some compscaram(o)uche-5/8/2017
11106Cara 1Q CC notes (some of this already known, perhaps, and is given as confirmattuck-5/4/2017
11105Thanks Nigel, I was wondering why Ablynx was green in a sea of red. AshleyA.J. Mullen-5/2/2017
11104We can now reasonably expect caplacizumab results this year. <i>GHENT, Benigel bates-5/2/2017
1110395 years of data...... cdec.water.ca.gov Small storm coming tonight. So, thisscaram(o)uche-4/12/2017
11102Re CARA human trials versus in vitro and in vivo data you posted: Let me be cletuck-4/6/2017
11101It would be interesting to see follow-up work in an in vivo knee injury model wituck-4/5/2017
11100Parking this abstract etc here, as this work is relevant for CARA. I do not wanBiotech Jim-4/5/2017
11099More on CARA: From Needham 3/28/17 markets.co From H.C. Wainwright 3/28/17 tJulius Wong-4/4/2017
11098A couple of points on CARA. Institutional holders appear to be few, at least iBiotech Jim-4/3/2017
11097Yes, I think that's the reason.DewDiligence_on_SI-4/3/2017
11096O/T that reason would be Redhat, yes? Cheers, Tucktuck-4/3/2017
11095I have to keep reminding myself that Redhill is a biotech company. For some reasDewDiligence_on_SI-4/3/2017
11094RDHL Redhill: In keeping with my unspoken policy of presenting my lesser known tuck-4/2/2017
11093I was thinking IV results would be out before oral results, but I see in their Jtuck-3/30/2017
11092CARA had registered a shelf offering on March 13 this year. It was for $250M. Biotech Jim-3/30/2017
11091crbp..... yummy, yummy..... sold 90% of position, plan to keep remainderIf the stuck-3/30/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News